Hypolipidemic Agents: all 738 studies that test it

Page 8 of 8. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and HypercholesterolemiaCompletedNCT00254475Phase 3
• Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic SubjectsCompletedNCT00246701Phase 3
• Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week ExtensionCompletedNCT00246636Phase 4
• Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIVCompletedNCT00246402Not applicable
• A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple SclerosisStatus unknownNCT00242268Phase 3
• The Low HDL On Six Weeks Statin Therapy (LOW) StudyStatus unknownNCT00238004Phase 4
• A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced VasospasmCompletedNCT00235963Phase 1/2
• Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial FunctionStatus unknownNCT00232531Not applicable
• A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to AtorvastatinCompletedNCT00195793Phase 3
• SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in HyperlipidemiaCompletedNCT00194402Phase 4
• Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial FunctionCompletedNCT00189085Phase 4
• Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor ExpressionStatus unknownNCT00176020Phase 1
• A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and HypercholesterolemiaCompletedNCT00171093Phase 3
• EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)CompletedNCT00166530Phase 4
• Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHDCompletedNCT00159835Phase 4
• Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)CompletedNCT00157924Phase 4
• Ezetimibe and Simvastatin in Dyslipidemia of DiabetesCompletedNCT00157482Phase 2
• EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple SclerosisCompletedNCT00146068Phase 4
• Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.TerminatedNCT00145431Phase 3
• Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With HypercholesterolemiaCompletedNCT00141141Phase 4
• Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. FenofibrateCompletedNCT00139061Phase 3
• A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)CompletedNCT00132717Phase 3
• Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering MeasuresCompletedNCT00125060Not applicable
• Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and TriglyceridesCompletedNCT00108511Phase 1
• A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)CompletedNCT00093899Phase 3
• Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)CompletedNCT00092573Phase 3
• Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)CompletedNCT00092560Phase 3
• Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)CompletedNCT00092157Phase 3
• Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOASTCompletedNCT00082251Phase 3
• Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)CompletedNCT00080275Phase 3
• The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)CompletedNCT00076518Phase 2
• The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPICCompletedNCT00071266Phase 3
• Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent ClaudicationCompletedNCT00062556Phase 3
• Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyCompletedNCT00053599Phase 3
• Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected PatientsCompletedNCT00046267Not applicable
• Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood LipidsCompletedNCT00006412Phase 3
• Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 DiabetesCompletedNCT00004266Phase 3
• Familial Atherosclerosis Treatment StudyCompletedNCT00000512Phase 3

← Hypolipidemic Agents overview